January 22, 2008 - Avista Capital Partners, which recently acquired the Bristol-Myers Squibb Medical Imaging medical imaging business unit, reported today that the FDA has granted pediatric exclusivity for studies conducted on Cardiolite, effective Jan. 8, 2008, extending the marketing exclusivity of Cardiolite for an additional six months beyond patent expiration on Jan. 29, 2008.

Cardiolite is a kit for the preparation of Technetium Tc99m Sestamibi for Injection.

January 22, 2008 - Researchers at the Universite de Montreal have run the largest mathematical simulation of a heart, a two billion element model, enabling discoveries of the electrical triggers of the various kinds of heart disease that could lead to earlier diagnosis and new treatments.

January 22, 2008 - Abiomed Inc. received FDA Humanitarian Device Exemption (HDE) supplement approval on system upgrades for its AbioCor Implantable Replacement Heart (AbioCor), intended to replace the severely damaged native heart for patients who are not eligible for a transplant and have no other treatment alternative.

January 23, 2008 - American healthcare can be greatly improved by embracing “openness” throughout the healthcare arena is the principle finding of a new report, Harnessing Openness to Transform American Health Care, released by the Digital Connections Council (DCC) of the Committee for Economic Development (CED).


Just when you got excited about CT angiography (CTA) noninvasively diagnosing coronary artery disease, the Centers for Medicare and Medicaid Services (CMS) decided to slash reimbursement for CTA.

January 22, 2008 – The FDA cleared by Cheetah Medical Inc.'s Reliant portable cardiac output monitor, designed to provide a noninvasive window to cardiac and hemodynamic function.

The Reliant monitor is powered by Cheetah's unique, patented BIOREACTANCE Technology, which has been used effectively in over 1,000 patients in various clinical settings including hemodynamic monitoring, heart failure, perioperative care, hemodialysis and stress testing.

January 22, 2008 - Cardica Inc. launched its new C-Port xA X-CHANGE Distal Anastomosis System, a cartridge-based, reloadable C-Port system designed for surgeons to attach multiple blood vessel grafts using the same handle during a coronary artery bypass graft (CABG) procedure, which is now available in the United States.

January 22, 2008 - The acute success rate for procedures using the new magnetic irrigated catheter by Stereotaxis to treat paroxysmal atrial fibrillation rose to 95 percent at sites that reported performing more than 20 cases, in a study presented at the Boston Atrial Fibrillation Symposium.

January 22, 2008 - Patients in the Columbus, OH, area are among the first in the U.S. to have been implanted with the Sleuth ECG Monitoring System, a wireless, implantable system for long-term monitoring of ECG (electrocardiogram) data for diagnosing cardiac arrhythmias behind unexplained fainting.

January 22, 2008 � The FDA approved enrollment expansion for a study, the Tailored Treatment of Permanent Atrial Fibrillation (TTOP AF), on the safety and efficacy of tailored ablation therapy against traditional pharmaceutical regimens, which will support a pre-market approval (PMA) application to the FDA.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now